Open AccessAdditional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: A dosimetric study
Author(s) -
Umesh Mahantshetty,
ManpreetSingh Tiwana,
Jamema Swamidas,
Sanjib K. Mishra,
Reena Engineer,
D. Deshpande,
Shyam Kishore Shrivastava
Publication year - 2011
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 1998-4138
pISSN - 0973-1482
DOI - 10.4103/0973-1482.87027
Subject(s) - brachytherapy , medicine , dose rate , cervix carcinoma , cervix , rectal carcinoma , nuclear medicine , radiology , rectum , radiation therapy , urology , cervical carcinoma , medical physics , colorectal cancer , cervical cancer , cancer
Late rectal and sigmoid toxicities seen in cervical cancer patients are attributed to brachytherapy despite rectal doses within tolerance limits. The purpose of this study was to identify additional dosimetric points which may better forecast rectal complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom